Journal Article
Predictors and trajectory of performance status in patients with advanced cancer: A secondary data analysis of the international European Palliative Care Cancer Symptom study
Boland, J. W., Allgar, V., Boland, E. G., Kaasa, S., Hjermstad, M. J., & Johnson, M. J. (2019). Predictors and trajectory of performance status in patients with advanced cancer: A secondary data analysis of the international European Palliative Care Cancer Symptom study. Palliative medicine, 33(2), 206-212. https://doi.org/10.1177/0269216318811011
Low agreement between mMRC rated by patients and clinicians - implications for practice
Ekstrom, M., Chang, S., Johnson, M., Fazekas, B., Kochovska, S., Huang, C., & Currow, D. (2019). Low agreement between mMRC rated by patients and clinicians - implications for practice. The European respiratory journal, 54(6), https://doi.org/10.1183/13993003.01517-2019
Low-intensity educational interventions supporting self-management to improve outcomes related to chronic breathlessness: a systematic review
Raymond, B., Johnson, M., Luckett, T., Hutchinson, A., Lovell, M., & Phillips, J. (2019). Low-intensity educational interventions supporting self-management to improve outcomes related to chronic breathlessness: a systematic review. NPJ Primary Care Respiratory Medicine, 29, https://doi.org/10.1038/s41533-019-0152-8
Intention-to-treat analyses for randomised controlled trials in hospice/palliative care: the case for analyses to be of people exposed to the intervention.
Currow, D. C., Higginson, I. J., Portenoy, R. K., Hussain, J. A., Kochovska, S., Huang, C., …Currow, D. C. (2019). Intention-to-treat analyses for randomised controlled trials in hospice/palliative care: the case for analyses to be of people exposed to the intervention. Journal of pain and symptom management, https://doi.org/10.1016/j.jpainsymman.2019.10.026
Randomised, double-blind, multi-centre, mixed-methods, dose-escalation feasibility trial of mirtazapine for better treatment of severe breathlessness in advanced lung disease (BETTER-B Feasibility)
Higginson, I., Wilcock, A., Johnson, M., Bajwah, S., Currow, D., Lovell, N., …Brown, S. (2020). Randomised, double-blind, multi-centre, mixed-methods, dose-escalation feasibility trial of mirtazapine for better treatment of severe breathlessness in advanced lung disease (BETTER-B Feasibility). Thorax, https://doi.org/10.1136/thoraxjnl-2019-213879